Patent analysis of key technologies for mRNA vaccines
10.13200/j.cnki.cjb.004533
- VernacularTitle:mRNA疫苗关键技术专利分析
- Author:
ZHAO Jianmin
- Publication Type:Journal Article
- Keywords:
mRNA vaccines;
Patent analysis;
Lipid nanoparticles;
Technical barriers;
Patent layout
- From:
Chinese Journal of Biologicals
2025;38(07):882-889
- CountryChina
- Language:Chinese
-
Abstract:
As a major breakthrough in biomedical field, mRNA vaccine technology has broad application prospects in the prevention and treatment of infectious diseases and tumor treatment. However, mRNA vaccines are a patent-intensive industry, and related core technology patents are mainly controlled by foreign companies. By analyzing the global patent application situation of key technology branches of mRNA vaccines and the differences between domestic and foreign enterprises' products and technology platforms, this paper constructs a patent barrier index model covering patent layout density and claim intensity, and systematically combs the technology competition pattern combined with patent dispute cases of leading enterprises, in order to provide ideas for domestic enterprises to break through patent barriers, optimize research and development paths and risk prevention and control strategies.
